CAMELA, ELISA
CAMELA, ELISA
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge
2022 Ruggiero, Angelo; Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Megna, Matteo
Paradoxical reactions to biologicals for psoriasis
2022 Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Megna, Matteo
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study
2022 Ruggiero, Angelo; Potestio, Luca; Cacciapuoti, Sara; Gallo, Lucia; Battista, Teresa; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al
2022 Camela, Elisa; Scalvenzi, Massimiliano; Megna, Matteo; Potestio, Luca; Guerrasio, Gianluca; Fornaro, Luigi; Fabbrocini, Gabriella; Costa, Claudia
A Case of Adult-onset Facial Cutaneous Mastocytoma: Clinical and Dermoscopic Findings
2022 Megna, M.; Scalvenzi, M.; Garza, S. S. O.; Fabbrocini, G.; Camela, E.
Towards Personalized Medicine in Psoriasis: Current Progress
2022 Camela, Elisa; Potestio, Luca; Ruggiero, Angelo; Ocampo-Garza, Sonia Sofia; Fabbrocini, Gabriella; Megna, Matteo
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series
2022 Megna, Matteo; Fabbrocini, Gabriella; Gallo, Lucia; Ruggiero, Angelo; Camela, Elisa; Sofía Ocampo-Garza, Sonia; Cinelli, Eleonora
Immune response to Covid‐19 mRNA vaccination in psoriasis patients undergoing treatment with biologics
2022 Megna, Matteo; Potestio, Luca; Battista, Teresa; Camela, Elisa; Genco, Lucia; Noto, Matteo; Fabbrocini, Gabriella; Martora, Fabrizio
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
2022 Megna, Matteo; Marano, Laura; Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Guerrasio, Gianluca
New frontiers in personalized medicine in psoriasis
2022 Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Ruggiero, Angelo; Megna, Matteo
Reply to "Routine re-screening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: a single-center retrospective cohort study"
2022 Ruggiero, Angelo; Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo
Reply to "Where are the older adults? Age distribution of nail psoriasis-randomized clinical trials' participants: a systematic review" by Ricardo JW et al
2022 Megna, Matteo; Camela, Elisa; Ruggiero, Angelo; Fabbrocini, Gabriella; Potestio, Luca
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience
2022 Ruggiero, Angelo; Martora, Fabrizio; Picone, Vincenzo; Potestio, Luca; Camela, Elisa; Battista, Teresa; Fabbrocini, Gabriella; Megna, Matteo
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study
2022 Megna, Matteo; Fornaro, Luigi; Potestio, Luca; Luciano, Maria Antonietta; Nocerino, Mariateresa; Delfino, Mario; Guarino, Maria; Fabbrocini, Gabriella; Camela, Elisa
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: results from an Italian single-centre retrospective study in a real-life setting
2022 Megna, Matteo; Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Ruggiero, Angelo
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation
2022 Megna, Matteo; Villani, Alessia; Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Ocampo-Garza, Sonia Sofia
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
2022 Ruggiero, Angelo; Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo
Treating psoriasis in the elderly: biologics and small molecules
2022 Megna, Matteo; Potestio, Luca; Fabbrocini, Gabriella; Camela, Elisa
Topical oil formulation of plant extracts and vitamins as effective treatment for stretch marks and xerosis—An observational longitudinal study
2021 Cantelli, M.; Camela, E.; Marasca, C.; Fontanella, G.; Blasio, C.; Fabbrocini, G.
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma
2022 Tranchini, Paolo; Costa, Claudia; Fabbrocini, Gabriella; Mascolo, Massimo; Russo, Daniela; Scalvenzi, Massimiliano; DE Fata Salvatores, Gaia; DI Guida, Adriana; Miano, Chiara; Marino, Vincenzo; Abategiovanni, Luisa; Nocerino, Mariateresa; Lauro, Wanda; Perrotta, Anna; Megna, Matteo; Camela, Elisa
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Megna, Matteo | |
Paradoxical reactions to biologicals for psoriasis | 1.1 Articolo in rivista | 2022 | Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Megna, Matteo | |
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Potestio, Luca; Cacciapuoti, Sara; Gallo, Lucia; Battista, Teresa; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo | |
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al | 1.7 Commento, erratum, replica e simili | 2022 | Camela, Elisa; Scalvenzi, Massimiliano; Megna, Matteo; Potestio, Luca; Guerrasio, Gianluca; Fornaro, Luigi; Fabbrocini, Gabriella; Costa, Claudia | |
A Case of Adult-onset Facial Cutaneous Mastocytoma: Clinical and Dermoscopic Findings | 1.1 Articolo in rivista | 2022 | Megna, M.; Scalvenzi, M.; Garza, S. S. O.; Fabbrocini, G.; Camela, E. | |
Towards Personalized Medicine in Psoriasis: Current Progress | 1.1 Articolo in rivista | 2022 | Camela, Elisa; Potestio, Luca; Ruggiero, Angelo; Ocampo-Garza, Sonia Sofia; Fabbrocini, Gabriella; Megna, Matteo | |
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Fabbrocini, Gabriella; Gallo, Lucia; Ruggiero, Angelo; Camela, Elisa; Sofía Ocampo-Garza, Sonia; Cinelli, Eleonora | |
Immune response to Covid‐19 mRNA vaccination in psoriasis patients undergoing treatment with biologics | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Potestio, Luca; Battista, Teresa; Camela, Elisa; Genco, Lucia; Noto, Matteo; Fabbrocini, Gabriella; Martora, Fabrizio | |
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Marano, Laura; Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Guerrasio, Gianluca | |
New frontiers in personalized medicine in psoriasis | 1.1 Articolo in rivista | 2022 | Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Ruggiero, Angelo; Megna, Matteo | |
Reply to "Routine re-screening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: a single-center retrospective cohort study" | 1.7 Commento, erratum, replica e simili | 2022 | Ruggiero, Angelo; Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo | |
Reply to "Where are the older adults? Age distribution of nail psoriasis-randomized clinical trials' participants: a systematic review" by Ricardo JW et al | 1.7 Commento, erratum, replica e simili | 2022 | Megna, Matteo; Camela, Elisa; Ruggiero, Angelo; Fabbrocini, Gabriella; Potestio, Luca | |
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Martora, Fabrizio; Picone, Vincenzo; Potestio, Luca; Camela, Elisa; Battista, Teresa; Fabbrocini, Gabriella; Megna, Matteo | |
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Fornaro, Luigi; Potestio, Luca; Luciano, Maria Antonietta; Nocerino, Mariateresa; Delfino, Mario; Guarino, Maria; Fabbrocini, Gabriella; Camela, Elisa | |
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: results from an Italian single-centre retrospective study in a real-life setting | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Ruggiero, Angelo | |
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Villani, Alessia; Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Ocampo-Garza, Sonia Sofia | |
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo | |
Treating psoriasis in the elderly: biologics and small molecules | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Potestio, Luca; Fabbrocini, Gabriella; Camela, Elisa | |
Topical oil formulation of plant extracts and vitamins as effective treatment for stretch marks and xerosis—An observational longitudinal study | 1.1 Articolo in rivista | 2021 | Cantelli, M.; Camela, E.; Marasca, C.; Fontanella, G.; Blasio, C.; Fabbrocini, G. | |
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma | 1.1 Articolo in rivista | 2022 | Tranchini, Paolo; Costa, Claudia; Fabbrocini, Gabriella; Mascolo, Massimo; Russo, Daniela; Scalvenzi, Massimiliano; DE Fata Salvatores, Gaia; DI Guida, Adriana; Miano, Chiara; Marino, Vincenzo; Abategiovanni, Luisa; Nocerino, Mariateresa; Lauro, Wanda; Perrotta, Anna; Megna, Matteo; Camela, Elisa |